High-Intensity Interval Training for Cognitive Function in Breast Cancer Patients
(CLARITY Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether a 16-week high-intensity interval training (HIIT) exercise program can improve brain health and heart function in women undergoing chemotherapy for breast cancer. Participants will be randomly assigned to either a HIIT exercise group or a stretching and relaxation group. Women newly diagnosed with stage I-III breast cancer and receiving chemotherapy might be suitable candidates, particularly if they exercise less than one hour per week and do not smoke. As an unphased trial, this study provides a unique opportunity to contribute to research that could enhance quality of life during cancer treatment.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
What prior data suggests that High-Intensity Interval Training (HIIT) is safe for breast cancer patients undergoing chemotherapy?
Research has shown that high-intensity interval training (HIIT) is generally safe for breast cancer patients. A review of 35 studies with 1,893 participants found that HIIT led to significant physical improvements, suggesting it is relatively safe for those undergoing cancer treatments. Many participants adhere to the HIIT program, with compliance rates between 57% and 83%, indicating it is manageable for most. Additionally, HIIT is linked to a roughly 20% lower risk of cancer recurrence and a reduced risk of death, enhancing its safety profile. While more research is needed, these findings support the potential safety and benefits of HIIT in breast cancer care.12345
Why are researchers excited about this trial?
Researchers are excited about using High-Intensity Interval Training (HIIT) for cognitive function in breast cancer patients because it offers a non-pharmacological approach to improving brain health. Unlike traditional treatments like medication or cognitive therapy, HIIT involves short bursts of intense exercise that can be done at home or in a clinic, making it more accessible and flexible. This method has the potential to enhance cognitive function by promoting better blood flow and brain plasticity, which are crucial for maintaining mental sharpness. Additionally, the exercise-based approach may also improve overall physical health, offering a holistic benefit that goes beyond cognitive improvement.
What evidence suggests that this trial's treatments could be effective for improving cognitive function in breast cancer patients?
Research has shown that High-Intensity Interval Training (HIIT), which participants in this trial may receive, can benefit breast cancer patients undergoing chemotherapy. Studies have found that HIIT improves heart and lung fitness and strengthens muscles. It might also reduce fatigue and emotional issues, common during chemotherapy. Early results suggest that HIIT could enhance brain health in breast cancer patients. Overall, HIIT offers a quick way to improve physical fitness and may enhance quality of life during treatment. Meanwhile, participants in the Attention Control group will engage in a home-based stretching program, serving as an active comparator in this trial.13678
Who Is on the Research Team?
Christina M Dieli-Conwright, PhD
Principal Investigator
Dana-Farber Cancer Institute
Are You a Good Fit for This Trial?
This trial is for women over 18 with early-stage breast cancer (Stage I-III) who will undergo chemotherapy, do less than an hour of exercise a week, don't smoke, and can travel to DFCI for assessments. They must not be pregnant or have lost significant weight recently, and if they can become pregnant, they need to use birth control and take a pregnancy test.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either High-Intensity Interval Training (HIIT) or Attention Control for 16 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Open-label extension (optional)
Participants in the Attention Control group may opt into the High-Intensity Interval Training (HIIT) program after the study ends
What Are the Treatments Tested in This Trial?
Interventions
- Attention Control
- High-Intensity Interval Training (HIIT)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Dana-Farber Cancer Institute
Lead Sponsor
American Institute for Cancer Research
Collaborator